Name: Commentary by Keith Kawashima | 2023 Top Risks Survey — Pharmaceuticals and Life Sciences
Uploaded: Tue, 01/10/2023 - 12:00
Description: Managing Director Keith Kawashima provides an overview of the risk landscape for pharmaceuticals and life sciences organizations based on research from Protiviti's 2023 Top Risks Survey.

Managing Director Keith Kawashima provides an overview of the risk landscape for pharmaceuticals and life sciences organizations based on research from Protiviti's 2023 Top Risks Survey.

Read 2023 Top Risks Manufacturing and Distribution Results

Industries

Manufacturing and Distribution

Leadership

Keith Kawashima

Keith Kawashima is a Managing Director and has over 30 years of experience in finance and accounting including 20+ years with Protiviti / Arthur Andersen's Internal Audit practice and 10+ years industry experience in both Finance and Operations prior to joining ...

Learn More

Search in Protiviti.com

Commentary by Keith Kawashima | 2023 Top Risks Survey — Pharmaceuticals and Life Sciences

Leadership

Keith Kawashima

Keith Kawashima is a Managing Director and has over 30 years of experience in finance and accounting including 20+ years with Protiviti / Arthur Andersen's Internal Audit practice and 10+ years industry experience in both Finance and Operations prior to joining ...